BOHEN SEAN (President and CEO) sold 31.2% of their position (109.50K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $986.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/11/2024ACC: 0001415889-24-029024
DirectorOfficer· President and CEO
Since Nov 2020
+95.25K
Net shares
Net buyer
$986.4K
Total sold
3
Open market trades
0B · 3S
4
Total transactions
204.75K acquired · 109.50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+204.75K
Price / share
—
Trade value
—
% of position
139.8%
12/9/2024
146.41K→351.16K
Common Stock
Direct
Shares
−52.33K
Price / share
$9.37
Trade value
$490.31K
% of position
14.9%
12/10/2024
351.16K→298.84K
Common Stock
Direct
Shares
−55.91K
Price / share
$8.66
Trade value
$484.15K
% of position
18.7%
12/11/2024
298.84K→242.93K
Common Stock
Direct
Shares
−1.27K
Price / share
$9.39
Trade value
$11.90K
% of position
0.5%
12/11/2024
242.93K→241.66K
Total
Net shares
+95.25K
Net value
-$986.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2024 | A · Award | +204.75K | — | — | 139.8% | 146.41K | 351.16K |
| Common Stock Direct | 12/10/2024 | S · Sale | −52.33K | $9.37 | $490.31K | 14.9% | 351.16K | 298.84K |
| Common Stock Direct | 12/11/2024 | S · Sale | −55.91K | $8.66 | $484.15K | 18.7% | 298.84K | 242.93K |
| Common Stock Direct | 12/11/2024 | S · Sale | −1.27K | $9.39 | $11.90K | 0.5% | 242.93K | 241.66K |
| Total | +95.25K | -$986.37K | ||||||
Derivative Transactions0
No derivative transactions reported